Clinical Trials Browser

Phase 1 × Glioblastoma × 3-aminopyridine-2-carboxaldehyde thiosemicarbazone × Clear all

NCT06860594 2026-03-18

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

Phase 1 Recruiting

Astrocytoma, Glioblastoma, Lymphoma, Follicular

NCT06410248 2025-12-19

Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma

Phase 1 Active not recruiting

Glioblastoma